The Myth of Mycotoxins and Mold Injury

Christopher Chang, M. Eric Gershwin

Research output: Contribution to journalReview article

Abstract

In recent years, mold has been blamed for many symptoms or a constellation of symptoms. These symptoms are usually vague and subjective and difficult or impossible to measure or quantify. Moreover, there is no scientific evidence that mold has anything to do with these symptoms. In particular, the concept of toxic mold syndrome has permeated the public consciousness, and mycotoxins have falsely been associated with autoimmune diseases and a variety of other conditions. In fact, there is no evidence that the presence of mycotoxins in the air is enough to cause any disease known to man. Molds legitimately can cause allergies and can be a trigger for asthma. Certain specific molds such as Aspergillus can be a cause of hypersensitivity pneumonitis. In immunocompromised hosts, both dermatologic and systemic infections can result from various fungi and can be associated with significant morbidity or even mortality. However, the existence of toxic mold syndrome has been disproven, despite the numerous disreputable practices such as testing homes for mold spores, measuring “mycotoxins” in the urine, and testing patients for IgG to mold. In truth, none of these techniques have been validated, nor do they have any relevance to any clinical disease. All that these tests that are being performed by laboratories of disrepute does is to further propagate misinformation and inflict unnecessary and often exorbitant costs on patients desperate for a clinical diagnosis, right or wrong, for their constellation of maladies.

Original languageEnglish (US)
Pages (from-to)449-455
Number of pages7
JournalClinical Reviews in Allergy and Immunology
Volume57
Issue number3
DOIs
StatePublished - Dec 1 2019

Fingerprint

Mycotoxins
Fungi
Wounds and Injuries
Poisons
Extrinsic Allergic Alveolitis
Immunocompromised Host
Aspergillus
Spores
Consciousness
Autoimmune Diseases
Hypersensitivity
Asthma
Immunoglobulin G
Communication
Air
Urine
Morbidity
Costs and Cost Analysis
Mortality

Keywords

  • Allergic bronchopulmonary aspergillosis
  • Allergic fungal sinusitis
  • Allergic rhinitis
  • Mold spores
  • Mycotoxins
  • Stachybotrys
  • Toxic black mold

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

The Myth of Mycotoxins and Mold Injury. / Chang, Christopher; Gershwin, M. Eric.

In: Clinical Reviews in Allergy and Immunology, Vol. 57, No. 3, 01.12.2019, p. 449-455.

Research output: Contribution to journalReview article

@article{ac8d3a16ea8b479fa5d1caa2df1b8dd7,
title = "The Myth of Mycotoxins and Mold Injury",
abstract = "In recent years, mold has been blamed for many symptoms or a constellation of symptoms. These symptoms are usually vague and subjective and difficult or impossible to measure or quantify. Moreover, there is no scientific evidence that mold has anything to do with these symptoms. In particular, the concept of toxic mold syndrome has permeated the public consciousness, and mycotoxins have falsely been associated with autoimmune diseases and a variety of other conditions. In fact, there is no evidence that the presence of mycotoxins in the air is enough to cause any disease known to man. Molds legitimately can cause allergies and can be a trigger for asthma. Certain specific molds such as Aspergillus can be a cause of hypersensitivity pneumonitis. In immunocompromised hosts, both dermatologic and systemic infections can result from various fungi and can be associated with significant morbidity or even mortality. However, the existence of toxic mold syndrome has been disproven, despite the numerous disreputable practices such as testing homes for mold spores, measuring “mycotoxins” in the urine, and testing patients for IgG to mold. In truth, none of these techniques have been validated, nor do they have any relevance to any clinical disease. All that these tests that are being performed by laboratories of disrepute does is to further propagate misinformation and inflict unnecessary and often exorbitant costs on patients desperate for a clinical diagnosis, right or wrong, for their constellation of maladies.",
keywords = "Allergic bronchopulmonary aspergillosis, Allergic fungal sinusitis, Allergic rhinitis, Mold spores, Mycotoxins, Stachybotrys, Toxic black mold",
author = "Christopher Chang and Gershwin, {M. Eric}",
year = "2019",
month = "12",
day = "1",
doi = "10.1007/s12016-019-08767-4",
language = "English (US)",
volume = "57",
pages = "449--455",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - The Myth of Mycotoxins and Mold Injury

AU - Chang, Christopher

AU - Gershwin, M. Eric

PY - 2019/12/1

Y1 - 2019/12/1

N2 - In recent years, mold has been blamed for many symptoms or a constellation of symptoms. These symptoms are usually vague and subjective and difficult or impossible to measure or quantify. Moreover, there is no scientific evidence that mold has anything to do with these symptoms. In particular, the concept of toxic mold syndrome has permeated the public consciousness, and mycotoxins have falsely been associated with autoimmune diseases and a variety of other conditions. In fact, there is no evidence that the presence of mycotoxins in the air is enough to cause any disease known to man. Molds legitimately can cause allergies and can be a trigger for asthma. Certain specific molds such as Aspergillus can be a cause of hypersensitivity pneumonitis. In immunocompromised hosts, both dermatologic and systemic infections can result from various fungi and can be associated with significant morbidity or even mortality. However, the existence of toxic mold syndrome has been disproven, despite the numerous disreputable practices such as testing homes for mold spores, measuring “mycotoxins” in the urine, and testing patients for IgG to mold. In truth, none of these techniques have been validated, nor do they have any relevance to any clinical disease. All that these tests that are being performed by laboratories of disrepute does is to further propagate misinformation and inflict unnecessary and often exorbitant costs on patients desperate for a clinical diagnosis, right or wrong, for their constellation of maladies.

AB - In recent years, mold has been blamed for many symptoms or a constellation of symptoms. These symptoms are usually vague and subjective and difficult or impossible to measure or quantify. Moreover, there is no scientific evidence that mold has anything to do with these symptoms. In particular, the concept of toxic mold syndrome has permeated the public consciousness, and mycotoxins have falsely been associated with autoimmune diseases and a variety of other conditions. In fact, there is no evidence that the presence of mycotoxins in the air is enough to cause any disease known to man. Molds legitimately can cause allergies and can be a trigger for asthma. Certain specific molds such as Aspergillus can be a cause of hypersensitivity pneumonitis. In immunocompromised hosts, both dermatologic and systemic infections can result from various fungi and can be associated with significant morbidity or even mortality. However, the existence of toxic mold syndrome has been disproven, despite the numerous disreputable practices such as testing homes for mold spores, measuring “mycotoxins” in the urine, and testing patients for IgG to mold. In truth, none of these techniques have been validated, nor do they have any relevance to any clinical disease. All that these tests that are being performed by laboratories of disrepute does is to further propagate misinformation and inflict unnecessary and often exorbitant costs on patients desperate for a clinical diagnosis, right or wrong, for their constellation of maladies.

KW - Allergic bronchopulmonary aspergillosis

KW - Allergic fungal sinusitis

KW - Allergic rhinitis

KW - Mold spores

KW - Mycotoxins

KW - Stachybotrys

KW - Toxic black mold

UR - http://www.scopus.com/inward/record.url?scp=85074538425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074538425&partnerID=8YFLogxK

U2 - 10.1007/s12016-019-08767-4

DO - 10.1007/s12016-019-08767-4

M3 - Review article

C2 - 31608429

AN - SCOPUS:85074538425

VL - 57

SP - 449

EP - 455

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 3

ER -